Idiopathic Noncirrhotic Intrahepatic Portal Hypertension  Is Associated with Sustained ADAMTS13 Deficiency

Idiopathic Noncirrhotic Intrahepatic Portal Hypertension Is Associated with Sustained ADAMTS13 Deficiency

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : Ian Mackie C. E. Eapen Desley Neil Andrew S. Lawrie Andrew Chitolie Jean C. Shaw Elwyn Elias
  • چاپ و سال / کشور: 2011

Description

Background ADAMTS13 deficiency leading to excess ultralarge vonWillebrand factor (VWF) multimers and platelet clumping is typically found in thrombotic thrombocytopenic purpura (a type of thrombotic microangiopathy). Idiopathic noncirrhotic intrahepatic portal hypertension (NCIPH) is a microangiopathy of portal venules associated with significant thrombocytopenia and predisposing gut disorders. Aim To determine whether the portal microangiopathy in NCIPH is associated with ADAMTS13 deficiency. Methods Plasma levels of ADAMTS13, anti-ADAMTS13 antibodies, andVWFwere compared between cases (NCIPH patients) and controls (with chronic liver diseases of other etiology) matched for severity of liver dysfunction. Eighteen NCIPH patients [median (range)MELDscore 12 (7–25)] and 25 controls [MELD score 11 (4–26)] were studied. Results ADAMTS13 activity was reduced in all 18 NCIPH patients and significantly lower than controls (median, IQR: 12.5%, 5–25% and 59.0%, 44–84%, respectively, P\0.0001) [normal range for plasma ADAMTS13 activity (55–160%)]. ADAMTS13 activity was\5% in 5/18 NCIPH patients (28%) and 0/25 controls (P = 0.009). ADAMTS13 antigen levels were also decreased. Sustained low ADAMTS13 levels were seen in four NCIPH patients over 6 weeks to 11 months (highest ADAMTS13 level in each patient: \5%, 6%, 6%, and 25%), despite two patients having MELD score 12. Although nine cases had low titer anti-ADAMTS13 antibodies, there was no significant difference between cases and controls. Abnormally large VWF multimers were observed in 4/11 NCIPH patients (36%) and in 0/22 controls (P = 0.008). Conclusions Sustained deficiency of ADAMTS13 appears characteristic of NCIPH, irrespective of severity of liver disease.
Dig Dis Sci (2011) 56:2456–2465 DOI 10.1007/s10620-011-1729-4 Received: 26 October 2010 / Accepted: 16 April 2011 / Published online: 15 May 2011
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری